David Fredrickson - AstraZeneca - LinkedIn
WEBBiopharmaceutical executive passionate about leading with purpose and uniting diverse…. · Experience: AstraZeneca · Location: Washington DC-Baltimore Area · 500+ connections on LinkedIn. View ...
- 500+ connections
- Location: AstraZeneca
Leadership - Our Company - AstraZeneca
WEBIntroducing AstraZeneca's Board of Directors, Senior Executives and Lead Scientists. Find information on each individual membership of the leadership team.
AstraZeneca and MSD hail progress in hard-to-treat cancers
WEB5 days ago · The treatment was AstraZeneca’s third-highest selling drug in 2023, with $4.2bn in sales. ... David Fredrickson, pointed out that the results showed progress in one subset of lung cancer ...
AstraZeneca places next ADC bet on in-house pipeline - Fierce …
WEBFeb 21, 2024 · AstraZeneca's David Fredrickson spoke to Fierce Biotech as the FDA accepted an application for the TROP2-directed ADC datopotamab deruxtecan.
Dave Fredrickson - Caris Life Sciences
WEBFredrickson currently serves as Executive Vice-President, Oncology Business Unit of AstraZeneca PLC, a position that he has held since October 2017. Previously, Mr. Fredrickson served as President of AstraZeneca K.K. in Japan, and Vice-President, Specialty Care of AstraZeneca in the United States.
AstraZeneca hails ‘clinically meaningful’ cancer drug trial results
WEBOct 23, 2023 · David Fredrickson, executive vice-president of oncology business at AstraZeneca, said it was a “massive achievement” in a “really ambitious programme” to be presenting two clinical trials —...
How we're taking steps to advance health equity at AstraZeneca …
WEBDec 15, 2021 · David Fredrickson. A year ago we made a commitment to dig into, and really understand, how AstraZeneca can play a leadership role in advancing health equity in the U.S.
David Fredrickson - Milken Institute
WEBMay 2, 2023 · Dave Fredrickson was appointed Executive Vice-President, Oncology Business Unit (OBU) in October 2017 and is responsible for driving growth and maximising the commercial performance of the AstraZeneca global oncology portfolio.
AstraZeneca's EVP on the potential of the pharma giant's new …
WEBSep 20, 2021 · AstraZeneca Executive Vice-President of the Oncology Business Unit David Fredrickson discusses the drugmaker's Enhertu breast cancer drug trial results.
AstraZeneca reports positive results in prostate cancer trial ...
WEBFeb 15, 2022 · David Fredrickson, executive vice-president for AstraZeneca’s oncology business unit, discusses the findings of the pharma company’s late-stage trial data for a new cancer drug, Lynparza.
Skip to content